Weixin Wang
Affiliations: | West Virginia University, Morgantown, WV, United States |
Area:
Cell BiologyGoogle:
"Weixin Wang"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yu B, Zheng L, Tang H, et al. (2021) Cucurbitacin B enhances apoptosis in gefitinib resistant non‑small cell lung cancer by modulating the miR‑17‑5p/STAT3 axis. Molecular Medicine Reports. 24 |
| Chen JH, Lin SS, Wang WX, et al. (2015) The extract, LXB-1, from the barks of Liriodendron × hybrid, induced apoptosis via Akt, JNK and ERK1/2 pathways in A549 lung cancer cells. Zeitschrift Fur Naturforschung. C, Journal of Biosciences. 70: 305-311 |
| Hair JM, Terzoudi GI, Hatzi VI, et al. (2010) BRCA1 role in the mitigation of radiotoxicity and chromosomal instability through repair of clustered DNA lesions. Chemico-Biological Interactions. 188: 350-8 |
| Wang W, Figg WD. (2008) Secondary BRCA1 and BRCA2 alterations and acquired chemoresistance. Cancer Biology & Therapy. 7: 1004-5 |
| DelloRusso C, Welcsh PL, Wang W, et al. (2007) Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation. Molecular Cancer Research : McR. 5: 35-45 |
| Wiltshire T, Senft J, Wang Y, et al. (2007) BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven. Molecular Pharmacology. 71: 1051-60 |
| Wang Y, Wiltshire T, Senft J, et al. (2007) Irofulven induces replication-dependent CHK2 activation related to p53 status. Biochemical Pharmacology. 73: 469-80 |
| Wang Y, Wiltshire T, Senft J, et al. (2006) Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven. Molecular Cancer Therapeutics. 5: 3153-61 |
| Wang J, Pabla N, Wang CY, et al. (2006) Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53. American Journal of Physiology. Renal Physiology. 291: F1300-7 |
| Wang J, Wiltshire T, Wang Y, et al. (2004) ATM-dependent CHK2 activation induced by anticancer agent, irofulven. The Journal of Biological Chemistry. 279: 39584-92 |